Smiths Detection to Expand Biological Capabilities with PathSensors Acquisition

Smiths Detection has entered into an agreement to acquire PathSensors, a leading bio-technology solutions and environmental-testing company based in Baltimore, MD.

The acquisition expands Smiths Detection’s sensing capabilities across the CBRNE (chemical, biological, radiological, nuclear and explosive) spectrum.

PathSensors provides high-speed, highly sensitive pathogen-detection and biothreat solutions and has developed a robust fieldable method of identifying biological threats in minutes.

The company shares a similar customer base to that which Smiths Detection serves for chemical-threat detection, while also allowing for expansion into adjacencies such as food and agricultural safety.

PathSensors offers multiple assays that are already available, at an independently verified speed and sensitivity data, which offer an opportunity to develop their future potential.

The transaction will enable Smiths Detection to accelerate its position in biological-detection capabilities.

“The acquisition of PathSensors will allow us to broaden our detection capabilities within the biological spectrum, which is becoming more relevant in the current environment,” said Roland Carter, President of Smiths Detection. “This is consistent with our approach to increase our focus on investing selectively in technology and innovation for the purpose of getting closer to our customers and expanding into new adjacencies.”

The contract is subject to customary closing conditions and is expected to conclude within the next four weeks. Details of the transaction have not been disclosed.

See latest Travel News, Video Interviews, Podcasts and other news regarding: COVID19, Smiths Detection, Security, Defence.